{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T01:22:33Z","timestamp":1784337753253,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T00:00:00Z","timestamp":1544832000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00296-018-4228-5","type":"journal-article","created":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T00:05:37Z","timestamp":1544832337000},"page":"359-365","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Thrombotic microangiopathy in a patient with eosinophilic granulomatosis with polyangiitis: case-based review"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0660-9186","authenticated-orcid":false,"given":"Jon","family":"Badiola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3354-4154","authenticated-orcid":false,"given":"Nuria","family":"Navarrete-Navarrete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4095-7379","authenticated-orcid":false,"given":"Jos\u00e9 Mario","family":"Sabio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,15]]},"reference":[{"key":"4228_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.autrev.2014.12.004","volume":"14","author":"A Greco","year":"2015","unstructured":"Greco A, Rizzo MI, De Virgilio A et al (2015) Churg-Strauss syndrome. Autoimmun Rev 14:341\u2013348","journal-title":"Autoimmun Rev"},{"key":"4228_CR2","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371:654\u2013666. \n                    https:\/\/doi.org\/10.1056\/NEJMra1312353","journal-title":"N Engl J Med"},{"key":"4228_CR3","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1182\/blood-2016-11-743104","volume":"129","author":"C Masias","year":"2017","unstructured":"Masias C, Vasu S, Cataland SR (2017) None of the above: thrombotic microangiopathy beyond TTP and HUS. Blood 129:2857\u20132863. \n                    https:\/\/doi.org\/10.1182\/blood-2016-11-743104","journal-title":"Blood"},{"key":"4228_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/jth.13571","volume":"15","author":"M Scully","year":"2017","unstructured":"Scully M, Cataland S, Coppo P et al (2017) Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost 15:312\u2013322. \n                    https:\/\/doi.org\/10.1111\/jth.13571","journal-title":"J Thromb Haemost"},{"key":"4228_CR5","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/1744-9987.12535","volume":"21","author":"A \u00c5kesson","year":"2017","unstructured":"\u00c5kesson A, Zetterberg E, Klintman J (2017) At the cross section of thrombotic microangiopathy and atypical hemolytic uremic syndrome: a narrative review of differential diagnostics and a problematization of nomenclature. Ther Apher Dial 21:304\u2013319. \n                    https:\/\/doi.org\/10.1111\/1744-9987.12535","journal-title":"Ther Apher Dial"},{"key":"4228_CR6","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/art.1780330806","volume":"33","author":"AT Masi","year":"1990","unstructured":"Masi AT, Hunder GG, Lie JT et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg\u2013Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094\u20131100","journal-title":"Arthritis Rheum"},{"key":"4228_CR7","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. \n                    https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"4228_CR8","doi-asserted-by":"publisher","first-page":"e1943","DOI":"10.1097\/MD.0000000000001943","volume":"94","author":"S Fukui","year":"2015","unstructured":"Fukui S, Iwamoto N, Tsuji S et al (2015) Eosinophilic granulomatosis with polyangiitis with thrombotic microangiopathy: is simultaneous systemic lupus erythematosus associated with clinical manifestations?: A case report and review of the literature. Medicine (Baltimore) 94:e1943. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000001943","journal-title":"Medicine (Baltimore)"},{"key":"4228_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s13730-017-0251-8","volume":"6","author":"M Cao","year":"2017","unstructured":"Cao M, Ferreiro T, Leite BN et al (2017) Two cases of atypical hemolytic uremic syndrome (aHUS) and eosinophilic granulomatosis with polyangiitis (EGPA): a possible relationship. CEN Case Rep 6:91\u201397. \n                    https:\/\/doi.org\/10.1007\/s13730-017-0251-8","journal-title":"CEN Case Rep"},{"key":"4228_CR10","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/ar4142","volume":"15","author":"D Song","year":"2013","unstructured":"Song D, Wu L, Wang F et al (2013) The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther 15:R12. \n                    https:\/\/doi.org\/10.1186\/ar4142","journal-title":"Arthritis Res Ther"},{"key":"4228_CR11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jash.2015.12.007","volume":"10","author":"RO Mathew","year":"2016","unstructured":"Mathew RO, Nayer A, Asif A (2016) The endothelium as the common denominator in malignant hypertension and thrombotic microangiopathy. J Am Soc Hypertens 10:352\u2013359. \n                    https:\/\/doi.org\/10.1016\/j.jash.2015.12.007","journal-title":"J Am Soc Hypertens"},{"key":"4228_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2169\/internalmedicine.49.2706","volume":"49","author":"Y Fujimura","year":"2010","unstructured":"Fujimura Y, Matsumoto M (2010) Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998\u20132008. Intern Med 49:7\u201315","journal-title":"Intern Med"},{"key":"4228_CR13","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2215\/CJN.07910814","volume":"10","author":"S-F Chen","year":"2015","unstructured":"Chen S-F, Wang H, Huang Y-M et al (2015) Clinicopathologic characteristics and outcomes of renal thrombotic microangiopathy in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis. Clin J Am Soc Nephrol 10:750\u2013758. \n                    https:\/\/doi.org\/10.2215\/CJN.07910814","journal-title":"Clin J Am Soc Nephrol"},{"key":"4228_CR14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.semarthrit.2013.11.004","volume":"43","author":"MH Rosove","year":"2014","unstructured":"Rosove MH (2014) Thrombotic microangiopathies. Semin Arthritis Rheum 43:797\u2013805. \n                    https:\/\/doi.org\/10.1016\/j.semarthrit.2013.11.004","journal-title":"Semin Arthritis Rheum"},{"key":"4228_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/BOR.0b013e32834bde57","volume":"24","author":"MM Timmeren van","year":"2012","unstructured":"van Timmeren MM, Heeringa P (2012) Pathogenesis of ANCA-associated vasculitis: recent insights from animal models. Curr Opin Rheumatol 24:8\u201314. \n                    https:\/\/doi.org\/10.1097\/BOR.0b013e32834bde57","journal-title":"Curr Opin Rheumatol"},{"key":"4228_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0065-2776(08)01003-1","volume":"101","author":"C Blanchard","year":"2009","unstructured":"Blanchard C, Rothenberg ME (2009) Biology of the eosinophil. Adv Immunol 101:81\u2013121. \n                    https:\/\/doi.org\/10.1016\/S0065-2776(08)01003-1","journal-title":"Adv Immunol"},{"key":"4228_CR17","doi-asserted-by":"publisher","first-page":"670","DOI":"10.2174\/157016112801784594","volume":"10","author":"A Maino","year":"2012","unstructured":"Maino A, Rossio R, Cugno M et al (2012) Hypereosinophilic syndrome, Churg\u2013Strauss syndrome and parasitic diseases: possible links between eosinophilia and thrombosis. Curr Vasc Pharmacol 10:670\u2013675","journal-title":"Curr Vasc Pharmacol"},{"key":"4228_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.iac.2015.04.002","volume":"35","author":"P Akuthota","year":"2015","unstructured":"Akuthota P, Weller PF (2015) Spectrum of eosinophilic end-organ manifestations. Immunol Allergy Clin N Am 35:403\u2013411. \n                    https:\/\/doi.org\/10.1016\/j.iac.2015.04.002","journal-title":"Immunol Allergy Clin N Am"},{"key":"4228_CR19","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1177\/1076029609348647","volume":"16","author":"PRJ Ames","year":"2010","unstructured":"Ames PRJ, Margaglione M, Mackie S, Alves JD (2010) Eosinophilia and thrombophilia in churg strauss syndrome: a clinical and pathogenetic overview. Clin Appl Thromb Hemost 16:628\u2013636. \n                    https:\/\/doi.org\/10.1177\/1076029609348647","journal-title":"Clin Appl Thromb Hemost"},{"key":"4228_CR20","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1111\/j.1523-1755.2005.00278.x","volume":"67","author":"H Liapis","year":"2005","unstructured":"Liapis H, Ho AK, Brown D et al (2005) Thrombotic microangiopathy associated with the hypereosinophilic syndrome. Kidney Int 67:1806\u20131811. \n                    https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00278.x","journal-title":"Kidney Int"},{"key":"4228_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.transci.2012.07.021","volume":"47","author":"C Yuste","year":"2012","unstructured":"Yuste C, Quiroga B, Verde E et al (2012) The non-casual relation between eosinophilia and thrombotic microangiopathy. Transfus Apher Sci 47:365\u2013367. \n                    https:\/\/doi.org\/10.1016\/j.transci.2012.07.021","journal-title":"Transfus Apher Sci"},{"key":"4228_CR22","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2169\/internalmedicine.48.2282","volume":"48","author":"H Ohguchi","year":"2009","unstructured":"Ohguchi H, Sugawara T, Harigae H (2009) Thrombotic thrombocytopenic purpura complicated with hypereosinophilic syndrome. Intern Med 48:1687\u20131690","journal-title":"Intern Med"},{"key":"4228_CR23","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1055\/s-0030-1262886","volume":"36","author":"M Quintrec Le","year":"2010","unstructured":"Le Quintrec M, Roumenina L, Noris M, Fr\u00e9meaux-Bacchi V (2010) Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes. Semin Thromb Hemost 36:641\u2013652. \n                    https:\/\/doi.org\/10.1055\/s-0030-1262886","journal-title":"Semin Thromb Hemost"},{"key":"4228_CR24","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1007\/s00467-010-1555-5","volume":"25","author":"D Kavanagh","year":"2010","unstructured":"Kavanagh D, Goodship T (2010) Genetics and complement in atypical HUS. Pediatr Nephrol 25:2431\u20132442. \n                    https:\/\/doi.org\/10.1007\/s00467-010-1555-5","journal-title":"Pediatr Nephrol"},{"key":"4228_CR25","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s00467-008-0872-4","volume":"23","author":"C Loirat","year":"2008","unstructured":"Loirat C, Noris M, Fremeaux-Bacchi V (2008) Complement and the atypical hemolytic uremic syndrome in children. Pediatr Nephrol 23:1957\u20131972. \n                    https:\/\/doi.org\/10.1007\/s00467-008-0872-4","journal-title":"Pediatr Nephrol"},{"key":"4228_CR26","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","volume":"124","author":"M Noris","year":"2014","unstructured":"Noris M, Galbusera M, Gastoldi S et al (2014) Dynamics of complement activation in aHUS and how to monitor eculizumab therapy. Blood 124:1715\u20131726. \n                    https:\/\/doi.org\/10.1182\/blood-2014-02-558296","journal-title":"Blood"},{"key":"4228_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","volume":"170","author":"H Xiao","year":"2007","unstructured":"Xiao H, Schreiber A, Heeringa P et al (2007) Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 170:52\u201364. \n                    https:\/\/doi.org\/10.2353\/ajpath.2007.060573","journal-title":"Am J Pathol"},{"key":"4228_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s10875-008-9268-2","volume":"29","author":"G Xing","year":"2009","unstructured":"Xing G, Chen M, Liu G et al (2009) Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis. J Clin Immunol 29:282\u2013291. \n                    https:\/\/doi.org\/10.1007\/s10875-008-9268-2","journal-title":"J Clin Immunol"},{"key":"4228_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ki.2012.313","volume":"83","author":"S-J Gou","year":"2013","unstructured":"Gou S-J, Yuan J, Chen M et al (2013) Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int 83:129\u2013137. \n                    https:\/\/doi.org\/10.1038\/ki.2012.313","journal-title":"Kidney Int"},{"key":"4228_CR30","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.2215\/CJN.00120115","volume":"10","author":"L Manenti","year":"2015","unstructured":"Manenti L, Vaglio A, Gnappi E et al (2015) Association of serum C3 concentration and histologic signs of thrombotic microangiopathy with outcomes among patients with ANCA-associated renal vasculitis. Clin J Am Soc Nephrol 10:2143\u20132151. \n                    https:\/\/doi.org\/10.2215\/CJN.00120115","journal-title":"Clin J Am Soc Nephrol"},{"key":"4228_CR31","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1681\/ASN.2012090884","volume":"24","author":"E Bresin","year":"2013","unstructured":"Bresin E, Rurali E, Caprioli J et al (2013) Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype. J Am Soc Nephrol 24:475\u2013486. \n                    https:\/\/doi.org\/10.1681\/ASN.2012090884","journal-title":"J Am Soc Nephrol"},{"key":"4228_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1182\/asheducation-2011.1.15","volume":"2011","author":"D Kavanagh","year":"2011","unstructured":"Kavanagh D, Goodship THJ (2011) Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations. Hematol Am Soc Hematol Educ Progr 2011:15\u201320. \n                    https:\/\/doi.org\/10.1182\/asheducation-2011.1.15","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"4228_CR33","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/CJN.02210310","volume":"5","author":"M Noris","year":"2010","unstructured":"Noris M, Caprioli J, Bresin E et al (2010) Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5:1844\u20131859. \n                    https:\/\/doi.org\/10.2215\/CJN.02210310","journal-title":"Clin J Am Soc Nephrol"},{"key":"4228_CR34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.transci.2016.04.011","volume":"54","author":"P Vieira-Martins","year":"2016","unstructured":"Vieira-Martins P, El Sissy C, Bordereau P et al (2016) Defining the genetics of thrombotic microangiopathies. Transfus Apher Sci 54:212\u2013219. \n                    https:\/\/doi.org\/10.1016\/j.transci.2016.04.011","journal-title":"Transfus Apher Sci"},{"key":"4228_CR35","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1084\/jem.20070301","volume":"204","author":"MC Pickering","year":"2007","unstructured":"Pickering MC, de Jorge EG, Martinez-Barricarte R et al (2007) Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. J Exp Med 204:1249\u20131256. \n                    https:\/\/doi.org\/10.1084\/jem.20070301","journal-title":"J Exp Med"},{"key":"4228_CR36","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2215\/CJN.04760512","volume":"8","author":"V Fremeaux-Bacchi","year":"2013","unstructured":"Fremeaux-Bacchi V, Fakhouri F, Garnier A et al (2013) Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol 8:554\u2013562. \n                    https:\/\/doi.org\/10.2215\/CJN.04760512","journal-title":"Clin J Am Soc Nephrol"},{"key":"4228_CR37","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ki.2012.63","volume":"82","author":"A Servais","year":"2012","unstructured":"Servais A, No\u00ebl L-H, Roumenina LT et al (2012) Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int 82:454\u2013464. \n                    https:\/\/doi.org\/10.1038\/ki.2012.63","journal-title":"Kidney Int"},{"key":"4228_CR38","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1093\/ndt\/gft220","volume":"28","author":"L Manenti","year":"2013","unstructured":"Manenti L, Gnappi E, Vaglio A et al (2013) Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature. Nephrol Dial Transplant 28:2246\u20132259. \n                    https:\/\/doi.org\/10.1093\/ndt\/gft220","journal-title":"Nephrol Dial Transplant"},{"key":"4228_CR39","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.molimm.2006.08.004","volume":"44","author":"G Monteferrante","year":"2007","unstructured":"Monteferrante G, Brioschi S, Caprioli J et al (2007) Genetic analysis of the complement factor H related 5 gene in haemolytic uraemic syndrome. Mol Immunol 44:1704\u20131708. \n                    https:\/\/doi.org\/10.1016\/j.molimm.2006.08.004","journal-title":"Mol Immunol"},{"key":"4228_CR40","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/jhg.2012.57","volume":"57","author":"D Westra","year":"2012","unstructured":"Westra D, Vernon KA, Volokhina EB et al (2012) Atypical hemolytic uremic syndrome and genetic aberrations in the complement factor H-related 5 gene. J Hum Genet 57:459\u2013464. \n                    https:\/\/doi.org\/10.1038\/jhg.2012.57","journal-title":"J Hum Genet"},{"key":"4228_CR41","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1111\/trf.13654","volume":"56","author":"A Li","year":"2016","unstructured":"Li A, Makar RS, Hurwitz S et al (2016) Treatment with or without plasma exchange for patients with acquired thrombotic microangiopathy not associated with severe ADAMTS13 deficiency: a propensity score-matched study. Transfusion 56:2069\u20132077. \n                    https:\/\/doi.org\/10.1111\/trf.13654","journal-title":"Transfusion"},{"key":"4228_CR42","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1182\/blood-2013-11-516237","volume":"123","author":"SR Cataland","year":"2014","unstructured":"Cataland SR, Wu HM (2014) How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome. Blood 123:2478\u20132484. \n                    https:\/\/doi.org\/10.1182\/blood-2013-11-516237","journal-title":"Blood"},{"key":"4228_CR43","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.2215\/CJN.01090209","volume":"4","author":"CJ Mache","year":"2009","unstructured":"Mache CJ, Acham-Roschitz B, Fr\u00e9meaux-Bacchi V et al (2009) Complement inhibitor eculizumab in atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 4:1312\u20131316. \n                    https:\/\/doi.org\/10.2215\/CJN.01090209","journal-title":"Clin J Am Soc Nephrol"},{"key":"4228_CR44","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre CM, Licht C, Muus P et al (2013) Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 368:2169\u20132181. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1208981","journal-title":"N Engl J Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-018-4228-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4228-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4228-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T19:21:07Z","timestamp":1576351267000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-018-4228-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,15]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4228"],"URL":"https:\/\/doi.org\/10.1007\/s00296-018-4228-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,15]]},"assertion":[{"value":"25 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"JB, NNN and JMS declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from the patient to publish this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}